ERBB2 and inflammatory breast carcinoma: From the expression of the first metagene in IBC and non-IBC we learned that IBC is characterised by a more frequent MAPK hyperactivation, which is reflected by the frequent overexpression of EGFR and/or ErbB2 in IBC compared to non-IBC.